谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Eversun: A Phase Ii Trial Of Everolimus Alternating With Sunitinib As First-Line Therapy For Advanced Renal Cell Carcinoma (Rcc) (Anzup Trial 0901).

Ian D. Davis,Val Gebski,Mark D. Chatfield,Peter S. Grimison,George Kannourakis,Amy L. Boland,Jennifer Thompson,Martin R. Stockler

JOURNAL OF CLINICAL ONCOLOGY（2012）

引用 2|浏览21
暂无评分
关键词
advanced renal cell carcinoma,sunitinib,first-line
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要